PRIMARY PERITONEAL CANCER
Clinical trials for PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough ovarian cancer? trial tests targeted drug vs standard chemo
Disease control TerminatedThis study tested a new drug, luveltamab tazevibulin, against standard chemotherapy in 600 women with ovarian cancer that had stopped responding to platinum-based treatment. The drug targets a protein called FOLR1 found on cancer cells. The trial was terminated early, so results …
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2, PHASE3 • Sponsor: Sutro Biopharma, Inc. • Aim: Disease control
Last updated May 17, 2026 02:14 UTC
-
Immune cells enlisted to fight hard-to-treat ovarian cancer
Disease control TerminatedThis early-phase study tested a new treatment for women with ovarian, fallopian tube, or peritoneal cancer that came back or didn't respond to standard chemotherapy. The approach involved taking a type of white blood cell (monocytes) from each participant, activating them with tw…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Scientists tap cancer fluids for clues
Knowledge-focused TerminatedThis study collected fluid from the abdomen or lungs, plus blood, from 22 adults with solid tumors. The goal was to learn more about how cancer works, not to test a new treatment. The information gathered may help researchers develop better ways to fight cancer in the future.
Matched conditions: PRIMARY PERITONEAL CANCER
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:38 UTC